Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia

		Phase:		Phase 1

		Treatment ID#:		1589 NCT00053963

		Age Group:		Pediatric Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Histologically confirmed malignancy Extracranial solid tumors or brain tumors* Diagnosis of leukemia allowed after maximum tolerated dose is determined NOTE: *Histology requirement waived for patients with brain stem or optic pathway tumors Disease must be refractory to conventional therapy or no effective conventional therapy exists CNS tumors resulting in neurological deficits must be stable for 2 weeks before study entry

		Last Updated:		11/11/2005

		Tumor Types:		Any Malignant Brain Tumor Meningioma Optic Glioma Recurrent Malignant Pediatric Brain Tumors


		Comments:

		Treatment Type:		Chemotherapy

		Contact:		H.S. Nicholson MD, MPH Doernbecher Children`s Hospital at Oregon Health & Science University Portland, OR 97239-3098 USA Phone: 503-494-1543 Fax: E-mail: Website:

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By